Please wait

Exhibit 107

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

Disc Medicine, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type		   Security
Class
Title		   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price Per
Unit		   Maximum
Aggregate
Offering
Price		   Fee
Rate		   Amount of
Registration
Fee(1)		   Carry
Forward
Form
Type		   Carry
Forward
File
Number		   Carry
Forward
Initial
effective
date		   Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         

Fees to Be

Paid

    Equity    Common stock, $0.0001 per share   457(r)   4,715,000 (2)    $55.00   $259,325,000    0.00015310    $39,702.66           
                         

Fees to Be

Paid

    Equity    Pre-funded warrants to purchase common stock   457(r)   181,818    $55.00 (3)    — (3)   0.00015310    — (3)          
                         

Fees

Previously
Paid

   —    —    —    —    —    —      —           
 
Carry Forward Securities
                         

Carry

Forward
Securities

   —    —    —    —      —        —    —    —    — 
                   
    Total Offering Amounts      $259,325,000      $39,702.66           
                   
    Total Fees Previously Paid          —            
                   
    Total Fee Offsets          —            
                   
    Net Fee Due                $39,702.66                 

 

(1)

Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). The fee payable in connection with the offering pursuant to this prospectus supplement has been paid in accordance with Rule 456(b) under the Securities Act, and represents deferred payment of the registration fees in connection with the registrant’s Registration Statement on Form S-3ASR (File No. 333-281359).

(2)

Includes 615,000 shares of common stock that the underwriters have an option to purchase and 181,818 shares of common stock that are issuable upon the exercise of the pre-funded warrants referenced below.

(3)

Represents the sum of the offering price of $54.9999 per pre-funded warrant and the exercise price of $0.0001 per share issuable pursuant to the pre-funded warrants. Pursuant to Securities and Exchange Commission staff interpretation, the entire fee is allocated to the common stock underlying the pre-funded warrants.